Related Experiment Video
Updated: May 21, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and
José M Miró1, José M Entenza, Ana Del Río
1Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain. jmmiro@ub.edu
Abstract:
We describe 3 patients with left-sided staphylococcal endocarditis (1 with methicillin-susceptible Staphylococcus aureus [MSSA] prosthetic aortic valve endocarditis and 2 with methicillin-resistant S. aureus [MRSA] native-valve endocarditis) who were successfully treated with high-dose intravenous daptomycin (10 mg/kg/day) plus fosfomycin (2 g every 6 h) for 6 weeks. This combination was tested in vitro against 7 MSSA, 5 MRSA, and 2 intermediately glycopeptide-resistant S. aureus isolates and proved to be synergistic against 11 (79%) strains and bactericidal against 8 (57%) strains. This combination deserves further clinical study.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Endocarditis I: Introduction
Myocarditis III: Medical Management
